Proportionality in Public Health Regulation: The Case of Dietary Supplements

被引:4
作者
Resnik D.B. [1 ]
机构
[1] National Institute of Environmental Health Sciences, National Institutes of Health, 111 Alexander Drive, Box 12233, Mail Drop E1-06, Research Triangle Park, Durham, 27709, NC
基金
美国国家卫生研究院;
关键词
Consumer choice; Dietary supplements; Ethics; Proportionality; Public health; Regulation; Safety;
D O I
10.1007/s41055-017-0023-3
中图分类号
学科分类号
摘要
The idea that the degree of infringement public health interventions have on individual rights should be proportional to the degree of expected benefits has emerged as an influential principle in public health ethics and policy. While proportionality makes sense in theory, it may be difficult to implement in practice, due to the inherent conflict between individual rights and the common good underlying the principle. To apply the proportionality principle to a decision of policy, one must still find a reasonable way of balancing these competing values in light of the available options and empirical evidence. In this article, I consider how the proportionality principle applies to the regulation of dietary supplements and examine some critiques of the current oversight system. I argue that it may be difficult maintain proportional oversight because the risks of dietary supplements vary considerably. Strengthening the regulations may therefore promote an appropriate level of regulation in some cases but lead to overregulation in others. © 2017, This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
引用
收藏
页码:1 / 16
页数:15
相关论文
共 77 条
[41]  
Lee L.M., Public health ethics theory: review and path to convergence, The Journal of Law, Medicine & Ethics, 40, 1, pp. 85-98, (2012)
[42]  
MacKay D., Regarding the regulation of dietary supplements, American Journal of Public Health, 105, 7, (2015)
[43]  
Marcus D.M., Grollman A.P., Botanical medicines--the need for new regulations, New England Journal of Medicine, 347, 25, pp. 2073-2076, (2002)
[44]  
Clinic M., Statin Side Effects: Weight the Benefits and Risks, (2016)
[45]  
McGuffin M., Should herbal medicines be regulated as drugs?, Clinical Pharmacology and Therapeutics, 83, 3, pp. 393-395, (2008)
[46]  
Mendeloff J., Does overregulation cause underregulation?, Regulation, 5, pp. 47-52, (1981)
[47]  
Miller H.I., To America’s health: a proposal to reform the food and drug administration, (2000)
[48]  
Morris C.A., Avorn J., Internet marketing of herbal products, Journal of the American Medical Association, 290, 11, pp. 1505-1509, (2003)
[49]  
Morrow J.D., Why the United States still needs improved dietary supplement regulation and oversight, Clinical Pharmacology and Therapeutics, 83, 3, pp. 391-393, (2008)
[50]  
National Center for Complementary and Integrative Medicine, Red Yeast Rice, (2016)